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The relevance of large clostridial toxin-negative, binary toxin-producing (A-B-CDT+) 27 
Clostridium difficile strains in human infection is still controversial. In this study, we 28 
investigated putative virulence traits that may contribute to the role of A-B-CDT+  29 
C. difficile strains in idiopathic diarrhoea. Phenotypic assays were conducted on 148 30 
strains of C. difficile comprising 10 different A-B-CDT+ C. difficile ribotypes (RTs): 31 
033, 238, 239, 288, 585, 586, QX143, QX444, QX521 and QX629. A subset of these 32 
isolates (n=53) was whole-genome sequenced to identify genetic loc  associated with 33 
virulence and survival. Motility studies showed that with the exception of RT 239 all 34 
RTs tested were non-motile. C difficile RTs 033 and 288 had deletions in the F2 and 35 
F3 regions of their flagella operon while the F2 region was absent from strains of RTs 36 
238, 585, 586, QX143, QX444, QX521 and QX629. The flagellin and flagella cap 37 
genes, fliC and fliD, respectively, involved in adherence and host colonization, were 38 
conserved in all strains, including reference strains. All A-B-CDT+ C. difficile strains 39 
produced at least three extracellular enzymes (deoxyribonuclease, esterase and 40 
mucinase) indicating that these are important extracellular proteins.  The toxicity of 41 
A-B-CDT+ C. difficile strains in Vero cells was confirmed, however, pathogenicity 42 
was not demonstrated in a mouse model of disease. Despite successful colonization 43 
by most strains, there was no evidence of disease in mice. This study provides the first 44 
in-depth analysis of A-B-CDT+ C. difficile strains and contributes to the current 45 







Clostridium difficile is a multi-host, anaerobic Gram-positive bacillus well known for 51 
causing enterocolitis (1).  It was initially described as part of the normal flora of the 52 
human neonatal gut in the 1930s, and then later detrmined to be a causative agent of 53 
antibiotic-associated pseudomembranous colitis (PMC) (2). Since then, C. difficile 54 
infection (CDI) has become the most commonly reported healthcare-associated 55 
infection (HAI) in the developed world (3). While a l rge proportion of CDI is HA-56 
CDI, community-associated (CA) CDI is increasing for reasons that are unclear, but 57 
possibly due to increased antimicrobial use or exposure to C. difficile spores in the 58 
community (4). The clinical symptoms of CDI range from mild to severe diarrhea and, 59 
in extreme cases, PMC that can lead to complications such as megacolon requiring 60 
surgical intervention (5).  61 
For many years the characterization of C. difficile centered on toxigenic strains that 62 
cause disease through the actions of the large clostridial toxins (A and/or B) while 63 
non-toxigenic C. difficile strains that did not produce either of these toxins were 64 
considered clinically irrelevant. Some strains of C. difficile also produce a bipartite 65 
ADP-ribosylating toxin (CDT, binary toxin), the significance of which remains 66 
controversial (7). There are many different ribotypes producing CDT, among them the 67 
fluoroquinolone-resistant PCR ribotype (RT) 027 strains that caused significant 68 
outbreaks in North America and Europe in the early 2000s and the equally virulent 69 
RT 078 (1, 6). Recently, some A-B-CDT+ C. difficile strains have been associated with 70 
idiopathic diarrhea, suggesting they may cause symptomatic infection (8-10). There 71 
are limited studies investigating the function(s) of CDT and its role in CDI.  It has 72 
been suggested that the production of CDT by A+B+ C. difficile strains increases their 73 
virulence (7, 11-14), however, recent contradictory studies demonstrated that patients 74 
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infected with CDT-producing C. difficile strains were just as likely to develop severe 75 
disease as patients infected with non-CDT producing C. difficile strains (15, 16, 17).   76 
While extensive efforts have been made to study C. difficile toxins, limited 77 
information is available on non-toxin related virulence factors, and only recently has 78 
there been any research focusing on other potential virulence factors such as adhesins, 79 
extracellular enzymes, flagella, capsules, metabolites and cell wall proteins (18, 19). 80 
These structures have been linked to virulence, colonization and survival of toxigenic 81 
C. difficile strains, however, their characterization has been c tered on highly 82 
prevalent toxigenic strains such as RTs 012, 014/020, 7 and 078 (6, 20-21). In this 83 
investigation, we sought to characterize putative virulence traits in A-B-CDT+ C. 84 
difficile strains. 85 
Materials and methods 86 
Bacterial isolate selection and identification 87 
C. difficile strains were selected based upon previous molecular analysis of RTs and 88 
toxin gene profiles. The strains (n=148) belonged to 10 RTs: 033, 238, 239, 288, 585, 89 
586, QX143, QX444, QX521 and QX629, and had been isolated from diverse sources 90 
(humans, n=28; foal, n=1; calves, n=52; pigs, n=40; food, n=1; piggery effluent, 91 
n=26).  The human clinical isolates originated from pathology laboratories around 92 
Australia, and the animal and environmental isolates were collected as part of 93 
previously reported Australian livestock and food prevalence studies (22, 23). Dr 94 
Frédéric Barbut (National Reference Laboratory for C. difficile, France) kindly 95 
contributed six human RT 033 isolates that originated from symptomatic patients in 96 
France (8). For comparative purposes for various assays, up to nine C. difficile strains 97 
belonging to RTs 010, 012, 014/020, 017, 023, 027, 33, 078 and 126 were included. 98 
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C. perfringens ATCC 13124 and Escherichia coli (strain K12) were also included as 99 
positive and negative controls, respectively, for detection of extracellular enzymes. 100 
Motility assay 101 
C. difficile strains were grown on horse blood agar (BA) plates (PathWest Media, 102 
Perth, Australia) anaerobically for 48 h to obtain pure cultures. Colonies from each 103 
culture were stab-inoculated into 2% brain heart infusion agar (BHIA, PathWest 104 
Media, Perth, Australia) and incubated anaerobically for 7 days. Motility was 105 
visualized and measured as secondary growth from the primary inoculant site. 106 
Substrate assays 107 
Seven assays to detect production of extracellular enzymes (hyaluronidase, esterase, 108 
heparinase, mucinase, gelatinase, lecithinase and deoxyribonuclease) were conducted 109 
on A-B-CDT+ C. difficile strains (n=118). Eight C. difficile strains of various RTs were 110 
included for comparison. C. perfringens  and E. coli were used as positive and 111 
negative controls, respectively. Detection of hyaluronidase, esterase, mucinase, 112 
deoxyribonuclease, gelatinase and lecithinase was performed as previously described 113 
(24-26). Briefly, pure cultures of strains were prepared on BA incubated anaerobically 114 
for 48 h and 2µL of 3.0 McFarland bacterial culture suspensions waspot-inoculated 115 
onto respective plates that were incubated anaerobically for 7 days. Nagler agar 116 
(PathWest Media, Perth, Australia) was used for lecithinase detection. The presence 117 
of precipitation or a zone of clearance around the inoculant area illustrated enzyme 118 
activity for each assay. For gelatinase, the medium was refrigerated at 4°C for 1 h 119 
(after incubation) before reading the results. Gelatinase activity was indicated by the 120 
medium remaining liquid. Heparinase was detected using the method described by 121 
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Riley (27). A positive result was recorded if the solution remained blue and for a 122 
negative result the solution turned purple-pink.  123 
Cell cytoxicity assay 124 
Vero (African green monkey kidney) cells were cultiva ed at 37ºC in 5% CO2 and 125 
Dulbecco’s modified Eagles medium (DMEM) supplemented with 10% fetal calf 126 
bovine serum, antimicrobials (100 µg/mL vancomycin, 200 µg/mL streptomycin 127 
sulphate), mycostatin, glutamate and a HEPES buffer (N-2-hydroxethylpiperazine-N1-128 
2-ethanesulfonic acid). Cells were passaged and trypsinized (0.2% trypsin-versene) at 129 
>90% confluency. A viable cell count was performed using 0.2% trypan blue dye in 130 
the KOVA® Glasstic® slide 10 (Hycor Biomedical Inc.) to determine cell density. 131 
Cells were reseeded to 6x104 cells/mL and returned to incubation prior to inoculation 132 
with bacterial filtrates. To activate the enzymatic component of CDT, filtered 133 
bacterial suspensions were trypsinized (200 µg/mL trypsin, Sigma-Aldrich) for 30 134 
min at 35°C and trypsinization was stopped using a trypsin inhibitor (400µg/mL final 135 
concentration, Sigma-Aldrich). Two-fold serial dilut ons of bacterial filtrates were 136 
performed across wells and the cytopathic effect (CPE) observed after 48-72 h of 137 
incubation. 138 
Mouse model assay 139 
Virulence trials using C57BL/6 mice were conducted on A-B-CDT+ C. difficile strains 140 
as previously described (28). Briefly, mice were pr-treated with an antimicrobial 141 
cocktail for 10 days to disrupt the resident microbiota and induce susceptibility to 142 
infection with C. difficile. On the day of infection, antimicrobial pre-treatment was 143 
ceased. Groups of 5 mice were infected with 105 C. difficile spores of the strains, 144 
AI0296 (RT 033), ES0618 (RT 585), ES0548 (QX143), ES145 (RT 288), JIR8301 145 
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(RT 033), NT077 (RT 033), SE23A (QX521), WA1997 (RT 033) and WAP0001 (RT 146 
238). C. difficile RT 027 strain M7404 was used as a positive control (28). The mice 147 
were monitored daily for signs of infection and faec l samples were analysed for the 148 
presence of C. difficile spores.  149 
In silico proteomic analysis 150 
Genomes of 53 representative A-B-CDT+ C. difficile strains were sequenced, 151 
assembled and annotated as described previously (29). Predicted genes of interest 152 
were compared to reference sequences using Artemis Comparison Tool (30) and the 153 
National Centre for Biotechnology Information (NCBI) GenBank 154 
http://www.ncbi.nlm.nih.gov/. The 53 annotated C. difficile genomes analysed in this 155 
study are freely available at figshare (http://dx.doi.org/10.6084/m9.figshare.7841426). 156 
Results 157 
Motility 158 
Motility studies showed that 9/10 A-B-CDT+ RTs tested including 033, 238, 288, 585, 159 
586, QX143, QX444, QX521 and QX629, as well as the ref rence RT 078 strain were 160 
non-motile. RTs 033 and 288 had deletions in F2 (glycosylation genes) and F3 (early-161 
stage flagella genes) regions of their flagella oper n. Seven ribotypes (238, 585, 586, 162 
QX143, QX444, QX521, QX629) retained the F1/F3 regions but lacked the 163 
glycosyltransferase genes (CD0241-CD0246) essential for C. difficile flagellum 164 
assembly and full motility phenotype. The flagella operon and the motility 165 
characteristic were conserved only in RT 239 and the C. difficile reference strains 166 
belonging to RTs 012 and 027 (Table 1). The flagellin and flagella cap genes, fliC and 167 
fliD, involved in adherence and host colonization were conserved in all strains, 168 
including the reference strains. All A-B-CDT+ strains tested also contained the four 169 
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additional late-stage flagella genes (CD0223-CD0226) found in reference strains 170 
R20291 (RT 027), M120 (RT 078), CD196 (RT 027) and R041 (RT 023) but absent 171 
in reference strains 630 (RT 012) and M68 (RT 017).  172 
Production of hydrolytic enzymes by A-B-CDT+ C. difficile strains 173 
There was heterogeneous production of extracellular enzymes by C. difficile isolates. 174 
All A -B-CDT+ C. difficile strains produced at least three extracellular enzymes 175 
(deoxyribonuclease, esterase, mucinase) (Table 2), indicating that these are important 176 
extracellular proteins. Hyaluronidase and gelatinase were produced by 93/118 (RTs 177 
033, 238, 288, 585, QX444, QX521) and 25/118 (RTs 033, 238, 288) A-B-CDT+ C. 178 
difficile strains, respectively. None of the C. difficile strains tested, including 179 
reference strains, produced lecithinase or heparinase. 180 
Effect of A-B-CDT+ C. difficile strains on Vero cells and in the mouse model 181 
Toxicity of the A-B-CDT+ C. difficile strains was confirmed in Vero cells (Figure 1) 182 
but not reproduced in vivo. Mice infected with A-B-CDT+ C. difficile strains all 183 
survived infection despite detection of high numbers of spores (107 CFU/g) in the 184 
faeces at either 24 or 96 h post-infection (Figure 2).  None had diarrhea except mice 185 
infected with C. difficile RT 585 (ES 0618). These mice had soft feces/diarrhe  24 h 186 
post-infection and showed weight loss, however, they recovered. Despite successful 187 
colonization by most of the strains, there was no obvious disease phenotype. As 188 
expected, the positive control strain M7404 (RT 027) caused 100% mortality in the 189 
mice, with rapid weight loss and death by day 2 post-infection. These mice showed 190 
the most severe damage to the cecum and colon, with large amounts of crypt 191 
hyperplasia, edema, epithelial damage and inflammation (data not shown), as seen 192 
before (28). 193 
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In silico analysis of A-B-CDT+ C. difficile strains 194 
Analysis of the annotated A-B-CDT+ C. difficile sequences identified specific 195 
elements and/ or genes that have been linked to transmission, survival and virulence 196 
in C. difficile. As expected, all the A-B-CDT+ C. difficile strains had an intact CDT 197 
locus. Essential genes associated with host cell attachment and bacterial adherence 198 
(slpA, cwps, fbpA, fliD, fliC), sporulation (spo0A, sodA, cotA-G, cotJB2), germination 199 
(sleC, cspC) and antimicrobial resistance (gyrA/B, vanB2 operon, tetM, blaR, cme, 200 
aph3-III-sat4A-ant6-Ia, aph3-III-sat4A-npmA- ant6-Ia) were identified in the isolates. 201 
A complete list of the identified genes is outlined in Table 3. 202 
Discussion 203 
Although several factors may contribute to the pathogenicity of C. difficile, toxins A 204 
and/or B have been considered the main virulence fators. In this study, all strains of 205 
C. difficile investigated produced only CDT, a toxin that has been observed 206 
increasingly in C. difficile but the role of which in disease remains unclear (7).  C. 207 
difficile CDT was first described in 1988 by Popoff et al. who detected it in the stool 208 
specimen of a 28-year-old woman with PMC (31). In co trast to toxins A and B, CDT 209 
possesses ADP-ribosyltransferase activity that acts specifically on actin (31). It 210 
modifies actin in gastrointestinal cells leading to its de-polymerization and inability to 211 
form filaments, eventually resulting in destruction f the cell cytoskeleton (31). 212 
Cytotoxicity of CDT produced by A-B-CDT+ C. difficile strains has been 213 
demonstrated in vitro, but not in vivo, although a role in immune modulation has been 214 
demonstrated recently (7, 32). In vitro cytotoxicity testing of all the A-B-CDT+ C. 215 
difficile RTs in the current study showed a CPE that was slightly different to the 216 
reference strain R20291 (Figure 1), but similar to cytotoxic effects previously 217 
observed with other ADP-ribosyltransferases (iota txin and C. spiroforme toxin) (33, 218 
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34). In addition to a potential role in immune modulation, C. difficile CDT induces 219 
long microtubule protrusions that form a network on the surface of epithelial cells, 220 
and these are hypothesized to increase bacterial adherence and hence promote 221 
colonization (33).  222 
Historically, hamsters have been extremely susceptibl  o CDI while the mouse is 223 
relatively resistant, presumably due to colonization resistance provided by the resident 224 
microbiota (35). None of the mice infected with A-B-CDT+ C. difficile RTs 225 
succumbed to disease, despite successful colonization (Figure 2). Previous animal 226 
studies using A-B-CDT+ C. difficile strains have reported contradictory results. In 227 
2006, Geric et al. reported that A-B-CDT+ C. difficile strains did not cause diarrhea or 228 
death in hamsters, however, the same strains caused marked fluid accumulation in 229 
rabbit ileal loops (36). After the introduction of the ClosTron technology, Kuenhe et 230 
al. performed a similar study.  Three out of nine hamsters died after infection with a 231 
mutant A-B-CDT+ C. difficile RT 027 strain while the rest exhibited atypical 232 
symptoms of “wet tail”, haemorrhage and inflammation f the small intestines, 233 
although these results were not statistically significant (17). Recent mouse model 234 
studies have shown that CDT produced by C. difficile RT 027 strains alters the host 235 
immune response resulting in increased tissue pathology (32). The specific role of 236 
CDT in CDI remains elusive and, given the difficulty of testing for the toxin in vitro, 237 
it is not surprising that information is limited. It is possible that the mouse model does 238 
not adequately demonstrate disease caused by A-B-CDT+ C. difficile strains or, 239 
perhaps, the presence of other putative virulence fa tors involved in locomotion, 240 
colonization, adherence and immunomodulation amplifies the virulence of certain A-241 
B-CDT+ C. difficile ribotypes. 242 
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The association between C. difficile locomotive organelles and C. difficile survival 243 
and colonization in humans and animals is also still not clear. Motility in most enteric 244 
pathogens provides the ability to relocate to nutrien  sources, evade dangerous 245 
environments and penetrate the mucous layer in the gut of their hosts. This ensures 246 
their growth and multiplication in the gut leading to colonization, an essential factor 247 
in the pathogenesis of most infections. Flagella are generally associated with 248 
swimming/swarming motility (20). Although they are considered crucial for most 249 
gastrointestinal pathogens, their relevance in the pathogenesis of CDI is still uncertain 250 
(20, 37). Of the 10 A-B-CDT+ C. difficile RTs (033, 238, 288, 585, 586, QX143, 251 
QX444, QX521 and QX629) tested in this study, nine w re non-motile, a 252 
characteristic they share with the successful MLST clade 5 C. difficile RT 078 strain 253 
highly prevalent in production animals and, more recently, human infection in North 254 
America and Europe (20, 37). Three of the 10 A-B-CDT+ RTs also had a genetic 255 
organisation of their flagella similar to RT 078; they lacked the F2 and F3 operons of 256 
the flagella and retained the F1 region including four additional genes, DTDP-4-257 
dehydrorhamnose reductase, glucose-1-phosphate thymidyl ltransferase, DTDP-4-258 
dehydrorhamnose 3,5-epimerase and DTDP-glucose 4,6-dehydratase, that are 259 
considered to play a role in virulence (37). Heterog neity within the flagella operons 260 
in C. difficile has been observed previously and is presumed to impact on various 261 
factors including adherence, toxin production, colonization and motility (20, 37). 262 
Currently, non-motile toxigenic strains such as the so-called hyper-virulent C. difficile 263 
RT 078 cause severe CDI in both humans and animals, suggesting that the role of the 264 
flagella in C. difficile virulence is either ribotype dependent or non-tradi ional (20, 37). 265 
Disruption of C. difficile flagella genes leads to increased and decreased expression of 266 
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PaLoc genes (20, 37). Hence, it is possible that flagel a genes are involved in the 267 
pathogenesis of CDI in a unique way.   268 
With regard to transmission, C. difficile spores play a contributory role in virulence 269 
and are responsible for 20-30% of CDI patients’ relapses due to their resistance to 270 
antimicrobials (38-40). Any changes in the compositi n of C. difficile spore proteins 271 
impacts on their functional capabilities and environmental dissemination (39, 40). 272 
Epidemic strains allegedly produce more spores compared to non-epidemic strains, 273 
however, this hypothesis was recently disputed due to inconsistencies in experimental 274 
designs (40). Spo0A is the key transcriptional regulatory protein for C. difficile 275 
sporulation and ultimate transmission (38, 39). In the present study, all the A-B-CDT+ 276 
C. difficile strains used to infect mice contained an intact spo0A gene and produced 277 
high numbers of spores (107 CFU/g) in their faeces at either 24 or 96 h post-infection 278 
(Figure 2). This suggested successful sporulation, and colonization of the mice by all 279 
the ribotypes tested.  280 
The vegetative form of C. difficile contains an array of surface layer proteins (SLPs) 281 
found on the outermost layer of the bacterium that m ke initial contact with human 282 
cells. Generally, they play important roles in the growth and survival of bacteria. In C.283 
difficile, they are also integral to adherence, stimulation of inflammation and 284 
induction of antibody responses by the host (41). Increased levels of anti-SLP IgM 285 
have been associated with decreased CDI recurrences (42). In this study, the A-B-286 
CDT+ C. difficile strains contained SLP-associated genes (Table 3) previously shown 287 
to illicit immune responses that may lead to further tissue damage (42-43). While C.288 
difficile SLPs may play a role in pathogenicity, recent studies suggest that they may 289 
be applicable to CDI treatment due to their immunogenicity (41-43). It is therefore 290 
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possible that A-B-CDT+ C. difficile SLPs play a protective rather than virulent role in 291 
CDI. 292 
Lastly, the production of extracellular enzymes by A-B-CDT+ C. difficile strains was 293 
demonstrated. As an asaccharolytic bacterium, C. difficile depends on small peptides 294 
for metabolism (44). C. difficile produces a subset of hydrolytic enzymes that are 295 
believed to aid in nutrient provision and colonization (44, 45). For instance, 296 
production of hyaluronidase by various strains of C. difficile has been previously 297 
reported in the literature (24). Hyaluronidase breaks down the substrate hyaluronate 298 
into hyaluronic acid and hyaluronan (46). Hyaluronate is a linear unsulfated 299 
gylcosaminoglycogan polymer that is a major component of connective tissues and 300 
fluids (46). This suggests that production of hyaluronidase by C. difficile promotes 301 
tissue damage and bacterial colonization. In fact, hyalurondase activity has been 302 
linked to adhesion and provision of important nutrients that ultimately promote 303 
establishment of C. difficile in the gut (46). Of the strains tested, 78.8% (93/118) of 304 
the A-B-CDT+ C. difficile isolates belonging to six RTs (033, 238, 288, 585, QX444, 305 
QX521) produced hyaluronidase. Heterogeneous producti n of hyaluronidase 306 
amongst the A-B-CDT+ C. difficile isolates correlates with the results of previous 307 
studies (24, 25). None of the C. difficile strains, including reference strains, produced 308 
lecithinase or heparinase. Lecithinase and heparinase have been linked to tissue 309 
infarction and necrosis in anaerobic bacteria, specifically C. perfringens (47). While 310 
previous work has demonstrated production of heparinase by some C. difficile strains, 311 
none of the A-B-CDT+ C. difficile strains produced heparinase (25, 49). Gelatinase 312 
production also varied amongst the tested C. ifficile strains with only 21.2% (25/118, 313 
RTs 033, 238, 288) of the A-B-CDT+ C. difficile strains producing gelatinase. This is 314 
similar to previous findings reported in the literature for toxigenic C. difficile (25, 49). 315 
14 
 
All  C. difficile strains tested (including reference strains) produce  DNase, esterase 316 
and mucinase, indicating that these are major and important extracellular proteins for 317 
these strains.  Our results contradict previous publications that did not detect 318 
production of DNase by C. difficile (49, 50). It is still unclear if these proteins act s 319 
virulence factors for C. difficile, however, the production of these bacterial 320 
extracellular products is thought to contribute to the survival and pathogenicity of 321 
bacteria in general and is likely to do so for A-B-CDT+ C. difficile strains (24, 50).  322 
Conclusion 323 
While much has been gleaned about C. difficile in the last two decades, the bacterium 324 
remains poorly understood. Recently we reported thepr sence of multiple 325 
antimicrobial resistance genes in A-B-CDT+ C. difficile strains (51). We have also 326 
demonstrated genetic relatedness and variability within these C. difficile isolates 327 
and other ST 11 C. difficile strains (52). Here we have extended that work by 328 
identifying factors that could play a role in the pathogenicity of these strains. The 329 
majority of A-B-CDT+ C. difficile strains tested produced survival, transmission and 330 
virulence factors (excluding toxins A and B) that are found in toxigenic C. difficile 331 
strains. Although it was not clear from our data tht these strains could cause disease 332 
solely, they have the potential to amplify disease if co-transmitted with a toxigenic 333 
strain. This study provides the first in-depth analysis of A-B-CDT+ C. difficile strains 334 
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Table 1: Distribution of flagella genes across different ribotypes of C. difficile isolates. 

















RT 033 A-B-CDT+ 11/5 + + - - Non-motile Human, n=16, calves, n=5, pigs, n=2, piggery effluent, n=4 and food, n=1 
RT 238 A-B-CDT+ 169/5 + + - + Non-motile Pigs, n=2 and calf, n=1 
RT 239 A-B-CDT+ 168/5 + + + + Motile Human, n=2 
RT 288 A-B-CDT+ 11/5 + + - - Non-motile Human, n=1 and calf, n=5 
RT 585 A-B-CDT+ 164/5 + + - + Non-motile Human, n=4 and foal, n=1 
RT 586 A-B-CDT+ 167/5 + + - + Non-motile Human, n=1 
QX 143 A-B-CDT+ 386/5 + + - + Non-motile Human, n=1 
QX 444 A-B-CDT+ 169/5 + + - + Non-motile Human, n=1 
QX 521 A-B-CDT+ 280/5 + + - + Non-motile Piggery effluent, n=5 
QX 629 A-B-CDT+ 315/5 + + - + Non-motile Human, n=1 
RT 012 A+B+CDT- 54/1 + - + + Motile Reference strain CD630 (NC_009089.1*), n=1 
RT 027 A+B+CDT+ 1/2 + + + + Motile Reference strain R20291 (FN545816.1*), n=1 
RT 078 A+B+CDT+ 11/5 + + - - Non-motile Reference strain M120 (NC_017174.1*), n=1 

















Extracellular enzyme, % (n) 
Deoxyribonuclease Esterase Mucinase Hyaluronidase Gelatinase Lecithinase Heparinase 
A-B-CDT+ C. difficile strains 
033 A-B-CDT+  Human n= 16, cattle n= 16, pigs n= 15, food n= 1, 
piggery effluent n= 10 
49.1% (58/118) 49.1% (58/118) 49.1% (58/118) 33.9% (44/118) 11.9% (14/118) 0% (0/118) 0% (0/118) 
288 A-B-CDT+  Human n= 1, cattle n= 16 14.4% (17/118) 14.4% (17/118) 14.4% (17/118) 2.5% (16/118) 2.5% (3/118) 0% (0/118) 0% (0/118) 
238 A-B-CDT+  Pigs n= 16 13.5% (16/118) 13.5% (16/118) 13.5% (16/118) 6.8% (16/118) 6.8% (8/118) 0% (0/118) 0% (0/118) 
239 A-B-CDT+  Human n= 1 0.85% (1/118) 0.85% (1/118) 0.85% (1/118) 0% (0/118) 0% (0/118) 0% (0/118) 0% (0/118) 
585 A-B-CDT+  Human n= 4, cattle n= 1 4.2% (5/118) 4.2% (5/118) 4.2% (5/118) 2.5% (3/118) 0% (0/118) 0% (0/118) 0% (0/118) 
586 A-B-CDT+  Human n= 1 0.85% (1/118) 0.85% (1/118) 0.85% (1/118) 0% (0/118) 0% (0/118) 0% (0/118) 0% (0/118) 
QX141 A-B-CDT+  Human n= 1 0.85% (1/118) 0.85% (1/118) 0.85% (1/118) 0% (0/118) 0% (0/118) 0% (0/118) 0% (0/118) 
QX143 A-B-CDT+  Human n= 1 0.85% (1/118) 0.85% (1/118) 0.85% (1/118) 0% (0/118) 0% (0/118) 0% (0/118) 0% (0/118) 
QX444 A-B-CDT+  Human n= 1 0.85% (1/118) 0.85% (1/118) 0.85% (1/118) 0.8% (1/118) 0% (0/118) 0% (0/118) 0% (0/118) 
QX521 A-B-CDT+  Piggery effluent n= 16 13.5% (16/118) 13.5% (16/118) 13.5% (16/118) 9.3% (13/118) 0% (0/118) 0% (0/118) 0% (0/118) 
QX629 A-B-CDT+  Human n= 1 0.85% (1/118) 0.85% (1/118) 0.85% (1/118) 0% (0/118) 0% (0/118) 0% (0/118) 0% (0/118) 
Total  Human n=27, cattle n=33, pigs n=31, food n=1, 
piggery effluent n=26 
100% (118/118) 100% (118/118) 100% (118/118) 79% (93/118) 21% (25/118) 0% (0/118) 0% (0/118) 
C. difficile comparator strains 
010[CD062] A-B-CDT-  n=1 Pos Pos Pos Neg Neg Neg Neg 
012[ATCC BAA-1382] A+B+CDT-  n=1 Pos Pos Pos Pos Pos Neg Neg 
017[ATCC 43598] A-B+CDT-  n=1 Pos Pos Pos Neg Pos Neg Neg 
023[Clos di 21] A+B+CDT+  n=1 Pos Pos Pos Neg Pos Neg Neg 
027[R20291] A+B+CDT+  n=1 Pos Pos Pos Neg Neg Neg Neg 
033[IS58] A-B-CDT+  n=1 Pos Pos Pos Pos Pos Neg Neg 
078[Wilcox078] A+B+CDT+  n=1 Pos Pos Pos Neg Pos Neg Neg 
126[CD6058625] A+B+CDT+  n=1 Pos Pos Pos Pos Pos Neg Neg 
Non-C. difficile control strains 
Clostridium perfringens ATCC 13124, n=1 Pos Pos Pos Pos Pos Pos Pos 
Escherichia coli (strain K12), n=1 Neg Neg Neg Neg Neg Neg NI 








   
 














Figure 2: C57BL/6J mice infected with 105 spores of the C. difficile strains. (A) Survival graph; (B) Weight loss graph; (C) Spore count at 24h; 
(D) Spore count at 96h; Positive control strain (M7404: A+B+CDT+); A-B-CDT+ strains (WA 1997, JIR 8301, NT 077, ES 0618, ES 0548, ES 




Table 3: Putative virulence proteins identified in A-B-CDT+ C. difficile strains, also considered putative 
virulent traits in toxigenic strains. 
 
Description Gene identifier Function Ribotype, n 
Toxin Production  
LytTR transcriptional 
regulator 
CD2603a Regulates binary toxin production7, 37 All b 
Adhesion, immunomodulation and motility 
Heat-shock inducible 
adhesin  
cwp66 Mediates bacterial adherence to host cell 37, 41 All b 
Cysteine protease  cwp84 Maturation and processing of the slpA layer, induces 
immune responses, breaks down gelatin, fibronectin, 
laminin and vitronectin proteins37, 41 
All b 
Cell wall binding proteins cwp2, cwp5, cwp8, 
cwp11, cwp13, 
cwp25 
Involved in adhesion and assembly of a fully functional s-
layer 37, 41 
All b 
Phase variable cell wall 
protein 
cwpV Bacterial aggregation, immune evasion37, 41 All b 
Major surface layer protein slpA Major contributor of host cell attachment and bacterial 
adherence37, 41 
All b 
Collagen-binding proteins CD2831a Collagen-binding protein, recognition of extracellular 
matrix collagen37 
All b 
Capsule CD3253a, CD0775a, 
CD2769a 





CD0514a Putative haemaglutinin37 All b 
Fibronectin-binding 
protein 
fbpA Enables adherence to host cells37 All b 
Flagellin proteins fliD, fliC Essential for fully functional flagella and involved in 
bacterial adherence to host cells20, 37 
All b 
Putative typeIV pilus CD3505a_CD3513a Putative type IV pilus biosynthesis and function37 All b 
Sortase CD2718a Class B sortase37 All b 
Transmission [sporulation and germination] 
Stage 0 sporulation protein 
A 
spo0A Sporulation transcription factor37, 39, 40 All b 
Superoxide dismutase sodA Stress response37, 39, 40 All b 
Spore coat proteins cotA, cotB, cotC, 
cotD, cotE, cotF, 
cotJB2, cotG 
Spore coat structure and morphogenesis37, 39, 40 All b 
Cortex hydrolase sleC Essential for spore germination37, 39, 40  All b 
Subtilisin-like serine 
protease 
cspC Protease that senses bile germinants and triggers activation 




ant6-Ia,   






Aminoglycoside resistance29, 51 RT 033 
[1/30] 
β-lactam resistance  blaR, cme β-lactam resistance29, 51 All b 
Fluoroquinolone resistance gyrA/B Fluoroquinolone resistance29, 51 RT 033 
[1/30] 
Glycopeptide resistance vanB2 operon  Vancomycin resistance29, 51 RT 033 
[1/30] 
Tetracycline resistance tetM Tetracycline resistance29, 51 RT 033 
[1/30] 
Adaptation and survival 
Cell lysis CD1546a Putative haemolysin like protein37 All b 
p-hydroxyphenylacetate 
decarboxylase  
hpdBCA Catalyzes the decarboxylation of p-hydroxyphenylacet te, 




CD1906a_CD1926a Ethanolamine degradation37 All b 
Oxidoreductase CD0065a Converts primary bile acid [chenodeoxycholic acid] into a 
secondary acid [7-keto-litholic acid]37 
All b 
Bile exclusion system CD32150a, 
CD32160a 




aC. difficile Reference strain 630 (RT 012) (Genbank NC_009089.1). b53 A-B-CDT+ C. difficile isolates (RTs 033, 





























• A-B-CDT+ C. difficile RTs have survival, transmission and putative virulence factors. 
• With the exception of RT 239 all A-B-CDT+ C. difficile RTs tested were non-motile. 
• All A-B-CDT+ C. difficile strains produced at least three extracellular enzymes. 
• Cytotoxicity of A-B-CDT+ C. difficile strains was demonstrated in vitro. 
• Pathogenicity was not seen in a mouse model despite successful colonisation. 
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